Efficacy of radiowave surgery in the treatment of patients with iris and ciliary body melanoma

Purpose: To determine the efficacy of resecting iris and ciliary body melanoma with the use of a 3.8-4.0-Mhz radiowave surgery unit. Material and Methods: This study was conducted at Department of Eye Cancer, the Filatov Institute, from 2005 through 2018. The study group involved 45 patients with...

Full description

Bibliographic Details
Main Authors: A.P. Maletskiy, O.V. Khomiakova
Format: Article
Language:English
Published: Ukrainian Society of Ophthalmologists 2020-01-01
Series:Journal of Ophthalmology
Subjects:
Online Access:https://www.ozhurnal.com/en/archive/2020/3/6-fulltext
_version_ 1797387073612677120
author A.P. Maletskiy
O.V. Khomiakova
author_facet A.P. Maletskiy
O.V. Khomiakova
author_sort A.P. Maletskiy
collection DOAJ
description Purpose: To determine the efficacy of resecting iris and ciliary body melanoma with the use of a 3.8-4.0-Mhz radiowave surgery unit. Material and Methods: This study was conducted at Department of Eye Cancer, the Filatov Institute, from 2005 through 2018. The study group involved 45 patients with iris and ciliary body melanoma; the mean age was 56.3 ± 2.2 years, with a slight female predominance (53.3%). Sixty-seven patients who had undergone iridociliary melanoma excision using a conventional technique with cutting tools were used as retrospective controls. The eye examination included visual acuity measurement, perimetry, biomicroscopy and ophthalmoscopy. Tumor, nodus и metastasis (TNM) staging was according to the American Joint Committee on Cancer (AJCC). No metastases were seen at the time of enrollment. The mean tumor prominence at baseline was 4.0 ± 0.3 mm, with a mean base diameter of 8.3 ± 0.4 mm, corresponding to a tumor volume of 34.3 ± 0.7 mm3. All the patients of each group were divided into two subgroups based on baseline visual acuity. The study group involved subgroup 1A (n=37 patients; 82.2%) with a visual acuity of 0.1 to 0.5 and subgroup 1B (n=8 patients; 17.8%) with a visual acuity of 0.6 to 0.8, and the retrospective control group involved subgroup 2A (n=55 patients; 82.1%) with a visual acuity of 0.1 to 0.5 and subgroup 2B (n=12 patients; 17.9%) with a visual acuity of 0.6 to 0.8 (p > 0.05). The analysis was performed by analysis of variance (ANOVA) using Statistica 13.0 (Dell Statsoft Inc., Austin, TX). Results: The radiosurgical approach to treatment of iridociliary tumors in our patients allowed significantly reducing the rates of intraoperative and postoperative complications (?2=4.16; df=1; p=0.04). In addition, the rates of intraoperative and postoperative complications for the treatment of iridociliary tumors with cutting instruments were 9.1% and 10.4%, respectively. The use of a radiowave surgery unit for uveal melanoma resection allowed preserving baseline visual acuity in all patients, with a tumor recurrence rate of not more than 2.2%. Conclusion: Early (12-month) treatment outcomes (visual functions and postoperative clinical course) and late treatment outcomes (visual functions; optic media; IOP; and tumor recurrence) for iridociliary melanoma resection using a radiowave 3.8-4.0 MHz unit allow us to state that high-frequency radiowave surgery enables reducing the risk of intraoperative and postoperative complications and, consequently, preserving a good visual function.
first_indexed 2024-03-08T22:19:30Z
format Article
id doaj.art-9eca35b9e4594332a7c4dff9299aa39b
institution Directory Open Access Journal
issn 2412-8740
language English
last_indexed 2024-03-08T22:19:30Z
publishDate 2020-01-01
publisher Ukrainian Society of Ophthalmologists
record_format Article
series Journal of Ophthalmology
spelling doaj.art-9eca35b9e4594332a7c4dff9299aa39b2023-12-18T15:37:23ZengUkrainian Society of OphthalmologistsJournal of Ophthalmology2412-87402020-01-013313610.31288/oftalmolzh202033136Efficacy of radiowave surgery in the treatment of patients with iris and ciliary body melanomaA.P. Maletskiy0O.V. Khomiakova1SI “The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine”SI “The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine”Purpose: To determine the efficacy of resecting iris and ciliary body melanoma with the use of a 3.8-4.0-Mhz radiowave surgery unit. Material and Methods: This study was conducted at Department of Eye Cancer, the Filatov Institute, from 2005 through 2018. The study group involved 45 patients with iris and ciliary body melanoma; the mean age was 56.3 ± 2.2 years, with a slight female predominance (53.3%). Sixty-seven patients who had undergone iridociliary melanoma excision using a conventional technique with cutting tools were used as retrospective controls. The eye examination included visual acuity measurement, perimetry, biomicroscopy and ophthalmoscopy. Tumor, nodus и metastasis (TNM) staging was according to the American Joint Committee on Cancer (AJCC). No metastases were seen at the time of enrollment. The mean tumor prominence at baseline was 4.0 ± 0.3 mm, with a mean base diameter of 8.3 ± 0.4 mm, corresponding to a tumor volume of 34.3 ± 0.7 mm3. All the patients of each group were divided into two subgroups based on baseline visual acuity. The study group involved subgroup 1A (n=37 patients; 82.2%) with a visual acuity of 0.1 to 0.5 and subgroup 1B (n=8 patients; 17.8%) with a visual acuity of 0.6 to 0.8, and the retrospective control group involved subgroup 2A (n=55 patients; 82.1%) with a visual acuity of 0.1 to 0.5 and subgroup 2B (n=12 patients; 17.9%) with a visual acuity of 0.6 to 0.8 (p > 0.05). The analysis was performed by analysis of variance (ANOVA) using Statistica 13.0 (Dell Statsoft Inc., Austin, TX). Results: The radiosurgical approach to treatment of iridociliary tumors in our patients allowed significantly reducing the rates of intraoperative and postoperative complications (?2=4.16; df=1; p=0.04). In addition, the rates of intraoperative and postoperative complications for the treatment of iridociliary tumors with cutting instruments were 9.1% and 10.4%, respectively. The use of a radiowave surgery unit for uveal melanoma resection allowed preserving baseline visual acuity in all patients, with a tumor recurrence rate of not more than 2.2%. Conclusion: Early (12-month) treatment outcomes (visual functions and postoperative clinical course) and late treatment outcomes (visual functions; optic media; IOP; and tumor recurrence) for iridociliary melanoma resection using a radiowave 3.8-4.0 MHz unit allow us to state that high-frequency radiowave surgery enables reducing the risk of intraoperative and postoperative complications and, consequently, preserving a good visual function.https://www.ozhurnal.com/en/archive/2020/3/6-fulltextuveal melanomaradiowave surgery unittreatment
spellingShingle A.P. Maletskiy
O.V. Khomiakova
Efficacy of radiowave surgery in the treatment of patients with iris and ciliary body melanoma
Journal of Ophthalmology
uveal melanoma
radiowave surgery unit
treatment
title Efficacy of radiowave surgery in the treatment of patients with iris and ciliary body melanoma
title_full Efficacy of radiowave surgery in the treatment of patients with iris and ciliary body melanoma
title_fullStr Efficacy of radiowave surgery in the treatment of patients with iris and ciliary body melanoma
title_full_unstemmed Efficacy of radiowave surgery in the treatment of patients with iris and ciliary body melanoma
title_short Efficacy of radiowave surgery in the treatment of patients with iris and ciliary body melanoma
title_sort efficacy of radiowave surgery in the treatment of patients with iris and ciliary body melanoma
topic uveal melanoma
radiowave surgery unit
treatment
url https://www.ozhurnal.com/en/archive/2020/3/6-fulltext
work_keys_str_mv AT apmaletskiy efficacyofradiowavesurgeryinthetreatmentofpatientswithirisandciliarybodymelanoma
AT ovkhomiakova efficacyofradiowavesurgeryinthetreatmentofpatientswithirisandciliarybodymelanoma